Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-5 of 5 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2020Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AMLDiNardo, C.D.; Tiong, I.S.; Quaglieri, A.; MacRaild, S.; Loghavi, S.; Brown, F.C.; Thijssen, R.; Pomilio, G.; Ivey, A.; Salmon, J.; Glytsou, C.; Fleming, S.A.; Zhang, Q.; Ma, H.; Patel, K.P.; Kornblau, S.M.; Xu, Z.; Chua, C.C.; Chen, X.; Blombery, P.; et al.
2020Association of reperfusion after thrombolysis with clinical outcome across the 4.5- to 9-hours and wake-up stroke time window: a meta-analysis of the EXTEND and EPITHET randomized clinical trialsCampbell, B.C.V.; Ma, H.; Parsons, M.W.; Churilov, L.; Yassi, N.; Kleinig, T.J.; Hsu, C.Y.; Dewey, H.M.; Butcher, K.S.; Yan, B.; Desmond, P.M.; Wijeratne, T.; Curtze, S.; Barber, P.A.; De Silva, D.A.; Thijs, V.; Levi, C.R.; Bladin, C.F.; Sharma, G.; Bivard, A.; et al.
2020Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient dataThomalla, G.; Boutitie, F.; Ma, H.; Koga, M.; Ringleb, P.; Schwamm, L.H.; Wu, O.; Bendszus, M.; Bladin, C.F.; Campbell, B.C.V.; Cheng, B.; Churilov, L.; Ebinger, M.; Endres, M.; Fiebach, J.B.; Fukuda-Doi, M.; Inoue, M.; Kleinig, T.J.; Latour, L.L.; Lemmens, R.; et al.
2022Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4ยท5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialMitchell, P.J.; Yan, B.; Churilov, L.; Dowling, R.J.; Bush, S.J.; Bivard, A.; Huo, X.C.; Wang, G.; Zhang, S.Y.; Ton, M.D.; Cordato, D.J.; Kleinig, T.J.; Ma, H.; Chandra, R.V.; Brown, H.; Campbell, B.C.V.; Cheung, A.K.; Steinfort, B.; Scroop, R.; Redmond, K.; et al.
2023Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE): A multicentre, prospective, randomised, open-label, blinded endpoint, controlled phase III non-inferiority trial protocolBivard, A.; Garcia-Esperon, C.; Churilov, L.; Spratt, N.; Russell, M.; Campbell, B.; Choi, P.; Kleinig, T.; Ma, H.; Markus, H.S.; Molina, C.; Hsu, C.Y.; Tsai, C.-H.; Meretoja, A.; Strbian, D.; Butcher, K.; Wu, T.Y.; Davis, S.M.; Donnan, G.; Levi, C.; et al.